BioVie Inc.: 10-Q filed 2014-01-29

Name: BioVie Inc.: 10-Q filed 2014-01-29
Creator: BioVie Inc.

What BioVie Inc. reported in its quarterly report filed 2014-01-29 (fiscal Q2 2014): 13 published measures, 25 facts as tagged in accession 0001552781-14-000047.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-01-29
Fiscal period: fiscal Q2 2014
Accession: 0001552781-14-000047 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioVie Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-12-31	406,827	USD
At 2013-06-30	505,696	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-12-31	390,077	USD
At 2013-06-30	490,696	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-04-10 to 2013-09-30	-17,510	USD	174

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-07-01 to 2013-12-31	-98,869	USD	184
2013-04-10 to 2013-12-31	-101,379	USD	266

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-04-10 to 2013-12-31	508,206	USD	266

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-12-31	406,827	USD
At 2013-06-30	505,696	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-12-31	16,750	USD
At 2013-06-30	15,000	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-06-30	15,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	47,282	USD	92
2013-07-01 to 2013-12-31	100,865	USD	184
2013-04-10 to 2013-12-31	118,380	USD	266

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	19,150	USD	92
2013-07-01 to 2013-12-31	30,010	USD	184
2013-04-10 to 2013-12-31	30,010	USD	266

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-12-31	87,060,000	shares
At 2013-06-30	87,060,000	shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-12-31	16,750	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	28,132	USD	92
2013-07-01 to 2013-12-31	70,855	USD	184
2013-04-10 to 2013-12-31	88,370	USD	266

Inspect the source

Entity: BioVie Inc. / CIK 0001580149
Captured: 2026-09-20T09:22:31.582Z
SEC response SHA-256: f572a001c48a2e876d70fd7a358ae1e5a994eab357401042d4f8aa6551a9ee85

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001580149.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))